BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 33724754)

  • 1. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
    Benson AB; Venook AP; Al-Hawary MM; Arain MA; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Farkas L; Garrido-Laguna I; Grem JL; Gunn A; Hecht JR; Hoffe S; Hubbard J; Hunt S; Johung KL; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Gregory KM; Gurski LA
    J Natl Compr Canc Netw; 2021 Mar; 19(3):329-359. PubMed ID: 33724754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
    Benson AB; Venook AP; Al-Hawary MM; Azad N; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Garrido-Laguna I; Grem JL; Gunn A; Hecht JR; Hoffe S; Hubbard J; Hunt S; Jeck W; Johung KL; Kirilcuk N; Krishnamurthi S; Maratt JK; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stotsky-Himelfarb E; Tavakkoli A; Willett CG; Gregory K; Gurski L
    J Natl Compr Canc Netw; 2022 Oct; 20(10):1139-1167. PubMed ID: 36240850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCCN Guidelines Insights: Colon Cancer, Version 2.2018.
    Benson AB; Venook AP; Al-Hawary MM; Cederquist L; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Engstrom PF; Garrido-Laguna I; Grem JL; Grothey A; Hochster HS; Hoffe S; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Murphy JD; Nurkin S; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Wuthrick E; Gregory KM; Freedman-Cass DA
    J Natl Compr Canc Netw; 2018 Apr; 16(4):359-369. PubMed ID: 29632055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCCN Guidelines Insights: Rectal Cancer, Version 6.2020.
    Benson AB; Venook AP; Al-Hawary MM; Arain MA; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Garrido-Laguna I; Grem JL; Gunn A; Hoffe S; Hubbard J; Hunt S; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Johnson-Chilla A; Gurski LA
    J Natl Compr Canc Netw; 2020 Jul; 18(7):806-815. PubMed ID: 32634771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
    Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA
    J Natl Compr Canc Netw; 2013 Feb; 11(2):141-52; quiz 152. PubMed ID: 23411381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
    Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA;
    J Natl Compr Canc Netw; 2013 May; 11(5):519-28. PubMed ID: 23667203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
    Flaig TW; Spiess PE; Agarwal N; Bangs R; Boorjian SA; Buyyounouski MK; Chang S; Downs TM; Efstathiou JA; Friedlander T; Greenberg RE; Guru KA; Guzzo T; Herr HW; Hoffman-Censits J; Hoimes C; Inman BA; Jimbo M; Kader AK; Lele SM; Michalski J; Montgomery JS; Nandagopal L; Pagliaro LC; Pal SK; Patterson A; Plimack ER; Pohar KS; Preston MA; Sexton WJ; Siefker-Radtke AO; Tward J; Wright JL; Gurski LA; Johnson-Chilla A
    J Natl Compr Canc Netw; 2020 Mar; 18(3):329-354. PubMed ID: 32135513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy and metastatic colorectal cancers with microsatellite instability or mismatch repair deficiency.
    Cohen R; Pellat A; Boussion H; Svrcek M; Lopez-Trabada D; Trouilloud I; Afchain P; André T
    Bull Cancer; 2019 Feb; 106(2):137-142. PubMed ID: 30327191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
    Benson AB; Venook AP; Cederquist L; Chan E; Chen YJ; Cooper HS; Deming D; Engstrom PF; Enzinger PC; Fichera A; Grem JL; Grothey A; Hochster HS; Hoffe S; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Mulcahy MF; Murphy JD; Nurkin S; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Wu CS; Gregory KM; Freedman-Cass D
    J Natl Compr Canc Netw; 2017 Mar; 15(3):370-398. PubMed ID: 28275037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Colon Cancers with Mutated BRAF and Microsatellite Instability.
    Matos P; Jordan P
    Adv Exp Med Biol; 2018; 1110():7-21. PubMed ID: 30623363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCCN Guidelines Updates: Management of Metastatic Colorectal Cancer.
    Messersmith WA
    J Natl Compr Canc Netw; 2019 May; 17(5.5):599-601. PubMed ID: 31117039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
    Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
    Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
    Sorscher S; Ansley K; Delaney SD; Ramkissoon S
    Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer.
    Morse MA; Overman MJ; Hartman L; Khoukaz T; Brutcher E; Lenz HJ; Atasoy A; Shangguan T; Zhao H; El-Rayes B
    Oncologist; 2019 Nov; 24(11):1453-1461. PubMed ID: 31147488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interpretation of the updates of NCCN 2017 version 1.0 guideline for colorectal cancer].
    Chen G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):28-33. PubMed ID: 28105616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal Cancer.
    Grothey A; Venook AP
    J Natl Compr Canc Netw; 2018 May; 16(5S):611-615. PubMed ID: 29784738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Updates and interpretation on NCCN clinical practice guidelines for gastric cancer 2017 version 5].
    Qiu H; Zhou Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):160-164. PubMed ID: 29492914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Updates for Colon Cancer Care in 2022.
    Fabregas JC; Ramnaraign B; George TJ
    Clin Colorectal Cancer; 2022 Sep; 21(3):198-203. PubMed ID: 35729033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer, version 3.2013: featured updates to the NCCN guidelines.
    Theriault RL; Carlson RW; Allred C; Anderson BO; Burstein HJ; Edge SB; Farrar WB; Forero A; Giordano SH; Goldstein LJ; Gradishar WJ; Hayes DF; Hudis CA; Isakoff SJ; Ljung BM; Mankoff DA; Marcom PK; Mayer IA; McCormick B; Pierce LJ; Reed EC; Schwartzberg LS; Smith ML; Soliman H; Somlo G; Ward JH; Wolff AC; Zellars R; Shead DA; Kumar R;
    J Natl Compr Canc Netw; 2013 Jul; 11(7):753-60; quiz 761. PubMed ID: 23847214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.